<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-08-11" id="root" itemid="791746" xml:lang="en">
<title>USA: KENSEY SAY FDA GRANTS EXPANDED SEAL USE.</title>
<headline>KENSEY SAY FDA GRANTS EXPANDED SEAL USE.</headline>
<dateline>EXTON, Pa. 1997-08-11</dateline>
<text>
<p>Kensey Nash Corp said Monday the U.S. Food and Drug Administration approved an expanded range of device users for its Angio-Seal puncture closure device.</p>
<p>The company said the Angio-Seal device may now be used by physicians, nurses, fellows, residents and other healthcare personnel.</p>
<p>The company's said the Angio-Seal device, its major product, seals arterial punctures created during common cardiac catheterization procedures such as diagnostic angiography, balloon angioplasty and placement of stents.</p>
<p>It said the Angio-Seal addresses a $1 billion market for sealing punctures created during the approximate six to seven million cardiac catheterizations performed worldwide each year.</p>
<p>Kensey Nash said it believes the Angio-Seal device is the first and only puncture closure device to have received such expanded user approval.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-08-11" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-08-11" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="EXTON, Pa." />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>